• About Us
    • Overview
    • Managament
    • Scientific Advisory Board
    • Supervisory Board
    • Collaborations
  • Our Research
    • Overview
    • Clinical Projects
    • Immunooncology
    • Synthetic Lethality
    • Collaborations
    • Publications
  • Pipeline
  • Investors & Media
  • Careers
    • Why work with is
    • Job Offers
    • Meet the company
    • About Cracow
    • Benefits
    • Recruitment Process
  • Contact Us
  • EN
  • PL

Report: Current Stock Reports

Title
  • Change of publication date of the annual report for 2022
    March 10, 2023

    Read More
  • Conclusion of an agreement concerning the operational execution of Phase II of Phase I/II clinical trial of RVU120 in Patients with Relapsed/Refractory Solid Tumors
    March 2, 2023

    Read More
  • Receipt from a person discharging managerial responsibilities in the Company of a correction to the Article 19 MAR notification
    February 6, 2023

    Read More
  • Notification from a person discharging managerial responsibilities in the Company – Article 19 of MAR
    February 3, 2023

    Read More
  • Notification from a person discharging managerial responsibilities in the Company – Article 19 of MAR
    February 3, 2023

    Read More
  • Achievement of the first milestone under licence agreement with Exelixis Inc.
    January 26, 2023

    Read More
  • Announcement of the NDS on registration of series J shares with the NDS
    January 25, 2023

    Read More
  • Publication dates for periodic reports in 2023
    January 25, 2023

    Read More
  • Notification from TFI Allianz Polska S.A. of a change in its share in the total number of votes in the Company
    January 25, 2023

    Read More
  • Admission and introduction of the series J shares of the Company to trading on the regulated market of the WSE
    January 20, 2023

    Read More

Posts navigation

Older posts
Contact Us
Ryvu Therapeutics [email protected] +48 12 297 46 90
Follow us
  • Privacy Policy
  • Cookies Policy
  • Sitemap
Copyright by Ryvu Therapeutics 2023
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy